DISCOVERY

DISCOVERY

Launched in 2024, Perceptive Discovery Fund (“Discovery”) is a closed-end fund focused on providing capital solutions to high conviction private and public life sciences company opportunities. The scope of Discovery investments will include bespoke structured financings, company building via asset aggregation and asset/company roll-up opportunities. Discovery is co-led by Konstantin Poukalov and Doug Giordano, who collectively have 50 years of deep transactional, executive and operational experience in the healthcare space. 

Discovery intends to provide structured solutions in the form of preferred equity and/or convertible debt to later-stage development and commercial-stage companies that require a quantum of capital to achieve operational success and drive value. While focusing on downside protection, these investments will endeavor to provide equity-linked upside with the goal of aligning investment results with our portfolio companies’ operational and financial objectives. 

Discovery will also look to partner with proven and experienced founders/entrepreneurs by carving-out and/or acquiring existing assets into a newco, and roll-up transactions where we believe significant value can be created by combining differentiated biomedical innovation, strong operational capabilities and sound financial strategies.